EDP Sciences logo
Submit your paper
Search
Menu
Home All issues Volume 17 / No 2 (Mai 2011) Med Buccale Chir Buccale, 17 2 (2011) 101-105 References
Open Access
Issue
Med Buccale Chir Buccale
Volume 17, Number 2, Mai 2011
Page(s) 101 - 105
Section Articles originaux / Original articles
DOI https://doi.org/10.1051/mbcb/2011111
Published online 25 April 2011
  1. Yamane Y, Aihara M, Ikezawa Z. Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan from 2000 to 2006. Allergol Int 2007;56:419-25. [CrossRef] [PubMed] [Google Scholar]
  2. Fromowitz JS, Ramos-Caro FA, Flowers FP. Practical guidelines for the management of toxic epidermal necrolysis and Stevens-Johnson syndrome. Int J Dermatol 2007;46:1092-4. [CrossRef] [PubMed] [Google Scholar]
  3. Tracey BM, Khue N. Une revue du syndrome de Stevens-Johnson et de la nécrolyse épidermique toxique. www.dermatologie conférences.ca 2005;4 (4). [Google Scholar]
  4. Gaultier F, Rochefort J, Landru MM, Allanore L, Naveau A, Roujeau JC, Gogly B. Severe and unrecognized dental abnormalities after drug-induced epidermal necrolysis. Arch Dermatol 2009;145:1332-3. [CrossRef] [PubMed] [Google Scholar]
  5. Koh MJ, Tay YK. An update on Stevens-Johnson syndrome and toxic epidermal necrolysis in children. Curr Opin Pediatr 2009;21:505-10. [CrossRef] [PubMed] [Google Scholar]
  6. Parrillo SJ. Stevens-Johnson syndrome and toxic epidermal necrolysis. Curr Allergy Asthma Rep 2007;7:243-7. [CrossRef] [PubMed] [Google Scholar]
  7. Sharma VK, Sethuraman G, Minz A. Stevens-Johnson syndrome, toxic epidermal necrolysis and SJS-TEN overlap : a retrospective study of causative drugs and clinical outcome. Indian J Dermatol Venereol Leprol 2008;74:238-40. [CrossRef] [PubMed] [Google Scholar]
  8. Sotozono C, Ueta M, Koizumi N, Inatomi T, Shirakata Y, Ikezawa Z, Hashimoto K, Kinoshita S. Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications. Ophthalmology 2009;116:685-90. [CrossRef] [PubMed] [Google Scholar]
  9. Knowles S, Shear NH. Clinical risk management of Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum. Dermatol Ther 2009;22:441-51. [CrossRef] [PubMed] [Google Scholar]
  10. Evans J. Topical treatment protocol for Stevens-Johnson syndrome and toxic epidermal necrolysis : a brief report. J Wound Ostomy Continence Nurs 2009;36:509-11. [CrossRef] [PubMed] [Google Scholar]
  11. Hazin R, Ibrahimi OA, Hazin MI, Kimyai-Asadi A. Stevens-Johnson syndrome : pathogenesis, diagnosis, and management. Ann Med 2008;40:129-38. [CrossRef] [PubMed] [Google Scholar]
  12. Sehgal VN, Srivastava G. Toxic epidermal necrolysis (TEN) Lyell’s syndrome. J Dermatolog Treat 2005;16:278-86. [CrossRef] [PubMed] [Google Scholar]
  13. Sedghizadeh PP, Kumar SK, Gorur A, Mastin C, Boros AL. Toxic epidermal necrolysis with a rare long-term oral complication requiring surgical intervention. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;105:e29-33. [CrossRef] [PubMed] [Google Scholar]
  14. Al-Johani KA, Fedele S, Porter SR. Erythema multiforme and related disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103:642-54. [CrossRef] [PubMed] [Google Scholar]
  15. Mukasa Y, Craven N. Management of toxic epidermal necrolysis and related syndromes. Postgrad Med J 2008;84:60-5. [CrossRef] [PubMed] [Google Scholar]
  16. French LE. Toxic epidermal necrolysis and Stevens-Johnson syndrome : our current understanding. Allergol Int 2006;55:9-16. [CrossRef] [PubMed] [Google Scholar]
  17. Bachot N, Roujeau JC. Differential diagnosis of severe cutaneous drug eruptions. Am J Clin Dermatol 2003;4:561-72. [CrossRef] [PubMed] [Google Scholar]
  18. Borchers AT, Lee JL, Naguwa SM, Cheema GS, Gershwin ME. Stevens-Johnson syndrome and toxic epidermal necrolysis. Autoimmun Rev 2008;7:598-605. [CrossRef] [PubMed] [Google Scholar]
  19. Koh MJ, Tay YK. An update on Stevens-Johnson syndrome and toxic epidermal necrolysis in children. Curr Opin Pediatr 2009;21:505-10. [CrossRef] [PubMed] [Google Scholar]
  20. Roujeau JC. Clinical heterogeneity of drug hypersensitivity. Toxicology 2005;15;209 :123-9. [CrossRef] [Google Scholar]
  21. Chia FL, Leong KP. Severe cutaneous adverse reactions to drugs. Curr Opin Allergy Clin Immunol 2007;7:304-9. [PubMed] [Google Scholar]
  22. Dieng MT, Ndiaye ST, Ndiaye B. Toxic epidermal necrolysis in Senegal : responsability of thioacetazone. Ann Dermatol Venerol 2001;128:1305-7. [Google Scholar]
  23. Struck MF, Hilbert P, Mockenhaupt M, Reichelt B, Steen M. Severe cutaneous adverse reactions : emergency approach to non-burn epidermolytic syndromes. Intensive Care Med 2010;36:22-32. [CrossRef] [PubMed] [Google Scholar]
  24. Farthing P, Bagan JV, Scully C. Mucosal disease series. Number IV. Erythema multiforme. Oral Dis 2005;11:261-7. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.